jina2023

larhondaz2969/jina2023

This file contains Unicode characters that might be confused with other characters. If you think that this is intentional, you can safely ignore this warning. Use the Escape button to reveal them.

monomoon.co.ukSRC:MixSentence, IDs:4001EF39;04EFBA12;D70F9551;FA6D331A;90C3508B;8655D580;723A698E;5AD61E1B;18073D02;41A18EFB;6B520626;8A521820;D7418648;60570297;0B4D3441;183CDF30;65591CD5;A2107323;878FED22;DCA74BA0;4783AC6E;DDF36E88;C5FF299B;176F41BE;F42FD8B5;BADFE870;FFB14DFC;ED732AD7;E39BB509;4DE6ED1A;9C9F8712;BCA08FF8;BF1C8051;7C03439F;A280F89D;07405E10;3EEB98CB;03EA264C;4BCDBA06;CE3E58BF;4CDE9612;AA48DA5E;167CCA31;AD2F6436;F78D37A9;75B58E06;1E951DB3;7D554A60
They use funny memes to get their ideas across but also do nice recap posts like the one above where they discuss their value proposition. And it’s wisdom: these aren’t ideas that you can search for on the internet; these are deep reflections on those ideas from a smart person who cares about them. Don’t let the title deceive you -- this book should be mandatory reading for anyone who creates for others, not just musicians. Don’t let the title fool you. Music is the title of the book, however, it could also say, your painting, or your basket weaving or printmaking. If that doesn’t convince you that you’ll love this book, gosh, then maybe it’s just not for you? The rest of the book, until page 132 is full of stories from Derek’s life on how he pursued his music. Each chapter was full of insights and actionable ideas. I’m not a musician but I’ve been able to apply the ideas to my work. Everyone from songwriters to artists will have a whole new view of the music business and how best to use your talents, your time, and all your resources after absorbing the many helpful and thought-provoking ideas and suggestions contained in this book.

monomoon.co.ukThis should be the same across all platforms. According to Hubspot, 87% of Gen X’ers and 70% of those ages 45-60 think brands should have a Facebook page. "Stop making Facebook the center of your relationship marketing efforts," says Nate Elliott, VP and Principal Analyst at Forrester. All of these big brands have spent a lot of time and money making sure you know their logo, colors, and what they stand for as a company by heart. You have to work for it by building a strategy, earning customers’ trust, and making your presence known on multiple channels. Whatever your strategy, you need to differentiate yourself from the competition to encourage customers to choose your business first. If you own a law office and your offices name on Google My Business is… Brand awareness happens the second someone remembers your brand from previously seeing something like your logo or company name.

SRC:MixSentence, IDs:34295D83;EB1A3FEA;18073D02;103B5D06;1F46BF33;7B5B1B10;5F6C8675;50E62F34;F8FC3409;EA15627F;BADFE870;5D6BC154;FCAFA917;9DDE16A1;C802490F;4001EF39;8AA5A084;75B58E06;0ECB4049;CEC0943E;6C181902;39C43B6E;DDF36E88;614C3861;6A28B5B1;226B4CE6;E39BB509;67343C2C;1F2180A7;A378FA11;5AD61E1B;371085E4;07431703;65591CD5;1FA912AD;60570297;FEAC54EB;102124F4;98BF5BC1;F1FE3AF6;6B520626;49E5C53D;00C312E8;42922DD0;8FA8DBD9;4EB90FA3;EC4F7400
With a clean, modern and sophisticated design. 0-$150 one-time): DIY platforms offer free article and premium themes; premium options provide better design and functionality. Firms already on Uptime Manage or Cloud legal services get the Starter tier free article. Yes. Plenty of law firms use SharePoint, especially solo attorneys and small practices that need basic file storage. A closer look at exactly which features separate a real legal document management system from basic file storage. Is SharePoint a document management system? A lot of law firms think document management is about storage. Firms that grow past a handful of people usually move to a document management system built specifically for matter-centric work. Because costs can build up long before any outcome is reached, firms must manage money carefully and maintain strong oversight. Yes, we all want more clients and billable work, but we need to narrow this down so that we can address on a very focused segment of our business and we can track the success of our hard work and well-earned money. File access from anywhere: Work from a mobile device, laptop, or tablet, wherever you need to be.

SRC:MixSentence, IDs:1CB5D976;485FA936;3AD5669B;AF24C528;430C4AF5;DE757C7F;4F45A2FE;24F2A662;99219F16;FC8C0D50;63624C40;F78D37A9;1F46BF33;4F03F29E;C54A2492;1FADB78C;0ECB4049;04EFBA12;6B520626;E73F66B8;EA15627F;F3096291;39C9A45B;CEC0943E;C0692D6E;48263096;62457DA4
If this is where clinical research is headed, that would be a terrible negative trajectory," he said. Dr. Topol - who drew attention last year with a finding that Celebrex and its competitor, Vioxx, appeared to raise the risk of heart attacks - said the Bextra studies did not include enough patients to justify drawing a broad conclusion. The average age of patients in the study, 23, did not represent the population likely to take the drug, he added. Yet through publication in the leading dental journal, the research helped Bextra's marketers shift attention away from the F.D.A.'s negative findings. Because of confidentiality rules, the F.D.A. cannot release any information about the earlier pain studies that failed to sway regulators. "Even though the study lacked some important proof, the real problem is that in the dental literature, this will be read," Dr. Topol said. "And dentists, who have to deal with trying to prevent or modulate pain, will be impressed." Judy Glova, a spokeswoman for Pharmacia, said the drug company stood behind the design and conclusions of the Scirex studies. Pharmacia was not trying to bypass the regulatory process, she said, adding that the company is in discussions with regulators to have Bextra approved for acute pain. Scirex executives did not return repeated phone calls. Editors at The Journal of the American Dental Association said the Scirex article was reviewed by at least three scientists. One reviewer, Dr. Paul A. Moore, an associate editor of the journal, said the study was "carefully designed and rigorously performed." But Dr. Moore said he would have recommended that the journal reject the paper had he known that Bextra was not approved for acute pain. The Bextra episode is just one example of the changing face of drug research. In the early 1990's, about 75 percent of the drug industry's clinical research dollars went to universities, according to a study by CenterWatch, a company that tracks clinical trials. By 2000, just 34 percent went to academic institutions, while the rest went to investigators working under the direction of either a private research firm like Scirex or a pharmaceutical company. Omnicom says it has no control over Scirex. "We have nothing to do with the design of clinical studies," said Pat Sloan, an Omnicom spokeswoman. Yet when the ad agency paid $20 million for part-ownership of Scirex in 1999, a top Omnicom executive, Thomas L. Harrison, said he expected Scirex's research to produce positive results for drug company clients - results that would help speed new-drug applications, or N.D.A.'s, to the F.D.A. "Our goal," he said, "is to help ensure that all clinical studies and each patient accrued into a study can be assessed to support the N.D.A.